| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/15/2005 | CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 06/15/2005 | CN1627970A Safety shield system for prefilled syringe |
| 06/15/2005 | CN1627945A Quinoline derivatives as NPY antagonists |
| 06/15/2005 | CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application |
| 06/15/2005 | CN1626532A Amide compounds |
| 06/15/2005 | CN1626234A Chinese herbal medicine for treating wind dampness and hyperosteogeny |
| 06/15/2005 | CN1626231A Chinese traditional medicine of diathermic tincture prepared from snake in use for activating blood, removing blood stasis, diminishing inflammation and relieving pain |
| 06/15/2005 | CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/15/2005 | CN1626223A Corypalis tablet and preparation method |
| 06/15/2005 | CN1626215A Chinese traditional medicine for treating rheumatoid arthritis, and preparing technique |
| 06/15/2005 | CN1626207A Preparation including unique ingredient and fabricating method |
| 06/15/2005 | CN1626205A Preparation for external use of Chinese traditional medicine for treating gout and preparation method |
| 06/15/2005 | CN1626198A Plaster for treating hyperosteogeny and arthralgia of winddampness |
| 06/15/2005 | CN1626194A Ointment for eliminating of toxicant and injuries from falls and docontusions |
| 06/15/2005 | CN1626193A Plaster for treating the bone disease |
| 06/15/2005 | CN1626190A Ointment for external application for treating hyperosteogeny and preparation method |
| 06/15/2005 | CN1626187A Medical paste for rheumatism and bone ache |
| 06/15/2005 | CN1626177A Powder injection of astragalus root and preparation method |
| 06/15/2005 | CN1626168A Leadwort (white snowflake) preparation |
| 06/15/2005 | CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 06/15/2005 | CN1626074A Preparation of Chinese traditional medicine |
| 06/15/2005 | CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/15/2005 | CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/15/2005 | CN1205997C Method of increasing bone toughness and stiffness and reducing fractures |
| 06/15/2005 | CN1205992C Medicine for treatment of ischemic necrosis of fermoral head |
| 06/15/2005 | CN1205989C Medicine composition for treating ischemic necrosis of femur head and preparing process thereof |
| 06/15/2005 | CN1205966C Bone-joining elixir and its preparation method |
| 06/15/2005 | CN1205959C Plaster for treating arthritis and cervical vertebra and vertebra lumbalis diseases |
| 06/14/2005 | US6906196 Antiinflammatory agents, rheumatic disorders |
| 06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906086 Methods for inhibiting bone loss |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6906044 Regeneration of articular cartilage damaged by grade I and II osteoarthritis by means of the intraarticular application of a mixture of sodium hyaluronate and chondroitin sulfate in a gel vehicle |
| 06/14/2005 | US6906041 Treatment of immune diseases |
| 06/14/2005 | US6905701 Formulations for transmucosal vaginal delivery of bisphosphonates |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905678 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 06/14/2005 | CA2346567C Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 06/14/2005 | CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity |
| 06/09/2005 | WO2005051912A1 Piperidine compound and method for producing same |
| 06/09/2005 | WO2005051407A1 Composition for preventing and treating climacteric symptoms comprising the extract of sophorae fructus |
| 06/09/2005 | WO2004105737A3 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 06/09/2005 | WO2004043956A8 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 06/09/2005 | US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124592 Administering tibolone to female patients to treat estrogen-deficiency related, climacteric complaints exhibited while the female patients are being treated with a drug to prevent the biosynthesis of endogenous estrogen; aromatase inhibitors to prevent bone loss; reduced side efffcts for cancer patients |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124050 Osteoclast differentiation inhibitors |
| 06/09/2005 | US20050124003 Using immunoaffinity selection to isolate and propagate pluripotent stem cell populations from fetal developmental tissues; cell replacement therapies |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123671 Incorporating trehalose into an edible aqueous system containing alpha glucosyl hesperidin or catechin or both followed by sterilization |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123609 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/09/2005 | US20050123603 Oral delivery vehicle; food products |
| 06/09/2005 | US20050123593 Chondroitin sulfate, keratinsulphate, heparin, heparin sulfate and dermatan sulfate encapsulated in a bilayer forming dipalmitoylphosphatidylcholine phospholipid; dosage; osteoarthritis |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | CA2547467A1 Piperidine compound and method for producing same |
| 06/09/2005 | CA2546861A1 Treatment of a condition in a mammal with administration of compounds and methods of use thereof |
| 06/09/2005 | CA2536188A1 Electrical devices and anti-scarring agents |
| 06/09/2005 | CA2536181A1 Polymer compositions and methods for their use |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537141A1 Parathyroid hormone-like polypeptides |
| 06/08/2005 | EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/08/2005 | EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 06/08/2005 | EP1537108A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 06/08/2005 | EP1537100A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 06/08/2005 | EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1537086A2 Novel phenanthridines |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 06/08/2005 | EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 06/08/2005 | EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/08/2005 | EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |
| 06/08/2005 | EP1536809A1 Use of fermented wheat germ extract as anti-inflammatory agent |
| 06/08/2005 | EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 06/08/2005 | EP1536806A1 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation |
| 06/08/2005 | EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/08/2005 | EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 06/08/2005 | EP1536786A1 Combination of an allosteric inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib |